BeiGene Ltd (HK:6160) has released an update.
BeiGene, Ltd., a biotechnology company incorporated in the Cayman Islands, has released an announcement pertaining to a new filing with the U.S. Securities and Exchange Commission. The document, a Form S-8 registration statement, was published on June 5, 2024, and relates to the company’s Third Amended and Restated 2016 Share Option and Incentive Plan as well as the Fourth Amended and Restated 2018 Employee Share Purchase Plan. The filing details are accessible on the SEC’s website, as informed by BeiGene’s chairman, Mr. John V. Oyler.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.
